Univest Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Univest Financial's VRTX Position: Q2 2026 in Review
Univest Financial increased its Vertex Pharmaceuticals (VRTX) stake by 28% in Q2 2026, buying an estimated $880K and bringing the position to 9,049 shares worth $4.49M. The position accounts for 0.22% of the portfolio, ranked #76.
Univest Financial first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Univest Financial held 9,049 shares of Vertex Pharmaceuticals worth $4.49M as of Q2 2026.
- Univest Financial bought 1,986 Vertex Pharmaceuticals shares in Q2 2026, an estimated $880K.
- Vertex Pharmaceuticals made up 0.22% of Univest Financial's portfolio in Q2 2026, its #76 holding.
- Univest Financial first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Univest Financial's 13F filing for Q2 2026, filed 7 Aug 2026.